Take the Diabetes Health Pump Survey
See What's Inside
Read this FREE issue now
For healthcare professionals only
  • 12 Tips for Traveling With Diabetes
See the entire table of contents here!

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter
Latest
Popular
Top Rated
Type 2 Issues Archives
Print | Email | Share | Comments (1)

Joint Statement Published from ADA and AACE on the NICE-SUGAR Study

The NICE-SUGAR Study looked at intensive versus conventional glucose control in critically ill patients

Mar 31, 2009

This press release is an announcement submitted by the American Association of Clinical Endocrinologists, and was not written by Diabetes Health.

The ADA and the AACE are adamant that the study’s findings should NOT lead to dismissal of good glucose management in hospitals. Uncontrolled high blood glucose can lead to serious problems for hospitalized patients, such as dehydration and increased propensity to infection.

The American Diabetes Association (ADA) and American Association of Clinical Endocrinologists (AACE) released a statement last week in response to the study published online in the New England Journal of Medicine which suggested that intensive blood glucose control for critical care patients with hyperglycemia doesn't improve outcomes and is associated with an increase in deaths.

The ADA and the AACE are adamant that the findings of the Normoglycemia in Intensive Care Evaluation-Survival Using Glucose Algorithm Regulation (NICE-SUGAR) study should NOT lead to an abandonment of the concept of good glucose management in the hospital setting. Uncontrolled high blood glucose can lead to serious problems for hospitalized patients, such as dehydration and increased propensity to infection.

It is important to consider that the severely ill patients in this trial were treated intensively with intravenous insulin to very tight targets (average of 115 mg/dl) and were compared to a control group whose glucose control was good (average glucose 144 mg/dl).

The ADA and AACE caution against letting this study swing the pendulum of glucose control too far in the other direction, where providers in hospitals may become complacent about uncontrolled hyperglycemia. The two organizations maintain that strategies must be identified to help hospitals establish structured protocols for safe and effective management of blood glucose in both intensive care units and other hospital settings.

"Since 2003, the AACE and the ADA have worked together to provide recommendations for treatment of inpatient hyperglycemia, and these efforts have contributed to a growing national movement viewing the management of hyperglycemia in hospitals as a quality care measure," said Dr. Etie S. Moghissi, AACE Chair of Inpatient Glycemic Control Task Force.

Recognizing the critical importance of controlling hyperglycemic states in conjunction with the results of recent randomized trials such as NICE-SUGAR, the two organizations recently convened a Consensus Panel to extensively review the most current literature and up-to-date recommendations for treatment of hyperglycemia in the hospital.

"The central goal of the ADA/AACE inpatient task force is to identify reasonable, achievable, and safe glucose targets and to describe the protocols, procedures, and system improvements needed to achieve inpatient optimal glucose control efficiently and safely," said Dr. Mary Korytkowski, ADA Chair of Inpatient Glycemic Control Task Force.

Complete recommendations from the panel will be published in Endocrine Practice and Diabetes Care later in the spring. Until more information is available, it seems reasonable for clinicians to treat critical care patients with the less intensive-yet good-glucose control strategies used in the conventional arm of the NICE-SUGAR trial.

About the NICE-SUGAR Study

Hyperglycemia in the hospital, whether it occurs in patients with known diabetes or is temporarily stress-induced, has long been known to be associated with poor outcomes such as longer length of stay, increased rates of infection, and in-hospital death. Observational studies and early randomized trials have suggested that lowering glucose levels can improve outcomes, especially in critical care patients treated with intravenous insulin to a range of 80 to 110 mg/dl. More recent studies in the critical care population were unable to replicate earlier studies and identified severe hypoglycemia (low blood glucose) as a significant risk of intensive glucose control. The NICE-SUGAR trial was a very large multi-center, multi-national study (with 6,104 participants) designed to definitively examine the risks and benefits of intensive glucose control in critical care units.

Results from the NICE-SUGAR study indicated that critically ill patients treated in the intensive glucose control group were 14 percent more likely to die compared to critically ill patients in the conventional glucose control group.

More than 6,100 patients with hyperglycemia in critical care units were randomized to either intensive glucose control (insulin infusion with target blood glucose between 80 and 108 mg/dl) or to conventional glucose control (insulin infusion begun if blood glucose was over 180 mg/dl and discontinued if blood glucose dropped below 144 mg/dl). Severe hypoglycemia (blood glucose below 40 mg/dl) occurred in approximately 6.8 percent of intensively treated patients, compared to 0.5 percent of conventionally treated patients. The study showed no difference in length of time in the intensive care unit or in the hospital, or in other major outcomes such as time on ventilators or need for dialysis.


Categories: Blood Glucose, Blood Sugar, Diabetes, Diabetes, Health Research, Insulin, Low Blood Sugar, Professional Issues, Type 1 Issues, Type 2 Issues



You May Also Be Interested In...


Comments

Posted by PNWmom on 9 April 2009

It may be that the large increase in severe hypoglycemia among patients with intensive blood sugar control is due to the low frequency of testing blood sugar. If nurses are not advised to test frequently, it's only natural that patients whose blood sugar is dropping won't be tended to until the reading is in the crisis range. How often did patients have their blood sugar tested in the NICE-SUGAR study? Intensive glucose testing should have been part of intensive glucose control. How often do patients with type one diabetes have their blood sugar tested in hospitals? Every 3 or 4 hours is not 'intensive' and where insulin is used for tight or even moderate control, testing every hour or two might result in better outcomes for patients. Just like at home. Continuous glucose monitoring might tell investigators more about best patient care practices than thousands of observations based on average blood sugar numbers.

Just a thought.


Add your comments about this article below. You can add comments as a registered user or anonymously. If you choose to post anonymously your comments will be sent to our moderator for approval before they appear on this page. If you choose to post as a registered user your comments will appear instantly.

When voicing your views via the comment feature, please respect the Diabetes Health community by refraining from comments that could be considered offensive to other people. Diabetes Health reserves the right to remove comments when necessary to maintain the cordial voice of the diabetes community.

For your privacy and protection, we ask that you do not include personal details such as address or telephone number in any comments posted.

Don't have your Diabetes Health Username? Register now and add your comments to all our content.

Have Your Say...


Username: Password:
Comment:
©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.